超声导向的Lipiodol®歇斯托索平学:关于怀孕和并发症率的前性研究
Glen Lo1,2,3,4, Dana Hince5, Neil Johnson6,7,8
1Western Ultrasound For Women, Perth, Western Australia, Australia.
The Australian & New Zealand journal of obstetrics & gynaecology
|February 1, 2024
概括
使用Lipiodol®的超声波导向囊造影 (HSG) 对于生育能力评估是安全的. 怀孕率与旧方法相似,但由于亚临床甲状腺功能低下的风险,监测甲状腺功能至关重要.
科学领域:
- 生殖医学 生殖医学
- 医疗成像医学成像
- 内分泌学 在内分泌学.
背景情况:
- 使用Lipiodol®的光学合镜 (HSG) 已被确立用于生育治疗.
- 超声波越来越喜欢HSG由于改善了患者的舒适性和缺乏电离辐射.
- 超声导向Lipiodol® HSG的安全性和有效性仍在调查中.
研究的目的:
- 用超声波引导的Lipiodol® HSG来前性评估怀孕和并发症的发生率.
- 评估这种新型成像技术在患有不明原因不孕症的女性中的安全性.
主要方法:
- 一个单一中心的前性研究,涉及有原因不明的不孕症的女性.
- 在初始的输卵管通透性确认后,进行了超声波引导的Lipiodol®子宫洗和输卵管冲洗.
- 术后记录了怀孕结果,甲状腺功能和疼痛评分.
主要成果:
- 招募了52名女性,其中45名女性完成了手术.
- 怀孕率包括57%的生物化学,53%的临床和35%的持续怀孕在六个月.
- 亚临床甲状腺功能低下症发生在41%的参与者中;在HSG手术期间发现了一例静脉注射. 没有观察到过敏反应或栓塞等严重不良事件.
结论:
- 门诊超声波引导的Lipiodol® HSG证明了安全性和与光镜方法相比的怀孕率.
- 血管内和亚临床甲状腺功能低下的发病率反映了先前的发现,强调了甲状腺功能监测的重要性.
- 超声导向的Lipiodol® HSG代表了一种可行的替代成像方式来评估生育能力.
更多相关视频
02:58Combination of High Ligation and Intraoperative Embolization using Polidocanol for Treatment of Varicoceles
Published on: December 22, 2023
395
03:01Author Spotlight: A Reproductive Hysteroscopy Approach for Complete Endometrial Polyp Removal and Enhanced Endometrial Receptivity
Published on: August 2, 2024
672
相关概念视频
Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Drugs for Treatment of Constipation-Predominant IBS
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
Development of the Oral Microbiota
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
